Chicago Health Care Ventures

The firm targets lower-middle-market healthcare companies with $2 million to $10 million of EBITDA, focusing on buyout transactions. Its investment focus spans three primary verticals: healthcare provider services, digital health platforms, and medical device manufacturers. The firm seeks founder-led businesses where it can add operational value.

Yes, according to the firm's website, Chicago Health Care Ventures is actively deploying capital from Chicago Health Care Ventures III. The fund is dedicated to healthcare buyout transactions. The firm has not publicly disclosed the fund's target size or final close amount.

Chicago Health Care Ventures sources deals through proprietary networks built around its healthcare-specific focus. The firm's website emphasizes long-standing relationships within the clinical and healthcare services communities. This sector concentration creates referral channels from industry operators, advisors, and physicians that generalist firms do not typically access.

The firm pursues control-oriented buyout transactions, not minority or growth equity investments. Its capital is deployed to acquire majority positions in healthcare companies. This buyout focus aligns with its operational playbook, which requires control to implement the back-office professionalization and service-line expansion strategies it brings to portfolio companies.

While headquartered in Chicago, the firm invests across the United States. Its deal sourcing and portfolio operations are managed from its single Chicago office. The firm's focus is on North American healthcare markets, consistent with the regulatory and reimbursement expertise required for US-based healthcare services and medical device companies.